思春期における再発予防のためのデジタル介入 (DigiTIFF)
青年期における再発予防のためのデジタル介入
Some adolescents experience periods of anxiety and/or depression, and some find that these periods return over time. The purpose of this study is to examine whether digital interventions-where individuals work systematically with their own thoughts and feelings during periods when they feel well-can help them maintain well-being for longer.
The study includes adolescents aged 16-19 who have previously experienced episodes of depression and/or anxiety to a degree that led them to seek help (e.g., from a school nurse, general practitioner, health clinic, or child and adolescent mental health service). Through a research app on their smartphones, participants complete tasks and answer questionnaires. The study is fully digital. Some participants meet with a therapist in digital group sessions, while others work independently with the digital content.
We will also examine the cost-benefit aspects of offering such interventions. If the study achieves its goals, digital interventions may eventually become a service offered to adolescents recovering from depression and anxiety.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前:Ragnhild Bø, Ph.D.
- 電話番号:+47 41904595
- メール:ragnhild.bo@psykologi.uio.no
研究場所
-
-
-
Oslo、ノルウェー
- 募集
- University of Oslo
-
コンタクト:
- Ragnhild Bø, PhD
- 電話番号:+47 41904595
- メール:ragnhild.bo@psykologi.uio.no
-
-
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Currently in full or partial remission for a minimum of 2 months from a depressive disorder or an anxiety disorder as defined by self-reported scores on RCADS-47: previous episode(s) of t-score > 65 and current t-score =<65.
- Native or fluent Scandinavian language skills.
- Willingness to take part even when allocated to the non-preferred arm of the trial.
Exclusion Criteria:
- Ongoing depressive disorder, ongoing anxiety disorder as defined by current t-score =<65 on RCADS-47.
- Recent completion of one of the interventions in the two interventional arms.
- no available smartphone.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:独身
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的:App intervention
A transdiagnostic, self-guided CBT app:
|
A transdiagnostic, self-guided CBT app, called TankeVirus (literally translated Thought Viruses), consisting of three components:
|
|
実験的:Group intervention
A transdiagnostic, mastery course for groups, delivered weekly in webinar format over three sessions. It includes videos and group discussions. |
Group-based webinar offering psychoeducation based on principles of CBT. |
|
介入なし:Assessment only
Only assessment will be conducted. |
この研究は何を測定していますか?
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Relapse: Number of participants scoring above the diagnostic cut-off on the PHQ-9 modified for teens during the 12-month follow-up.
時間枠:From enrollment to the end of follow-up at 12-months.
|
To use the PHQ-9 as a diagnostic aid for Major Depressive Disorder:
|
From enrollment to the end of follow-up at 12-months.
|
|
Time until relapse; reaching the diagnostic criteria of MDD according to PHQ-9 modified for teens
時間枠:From enrollment to 12-months follow-up
|
Number of days until the diagnostic criteria of MDD as assessed PHQ-9 modified for teens has been reached. - Questions 1 and/or 2 need to be endorsed as a "2" or "3"
|
From enrollment to 12-months follow-up
|
二次結果の測定
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Repetitive negative thinking (RNT-10)
時間枠:At enrollment, and at 3, 6 and 12 months follow-up
|
Assess transdiagnostic repetitive negative thinking |
At enrollment, and at 3, 6 and 12 months follow-up
|
|
Somatic complaints (SSS8)
時間枠:At enrollment, and at 3, 6, and 12-months follow-up.
|
Somatic complaints based on sum score of all items |
At enrollment, and at 3, 6, and 12-months follow-up.
|
|
EPOCH Measure of Adolescent Well-Being
時間枠:At baseline, 3, 6 and 12-months follow-up.
|
A 20-item validated questionnaire (4 items per domain; Engagement, Perseverance, Optimism, Connectedness, Happiness) on a 1-5 Likert scale (1=Almost Never, 5=Almost Always) resulting in domain scores, reflecting strengths in these positive psychological areas crucial for youth well-being. |
At baseline, 3, 6 and 12-months follow-up.
|
|
Health related quality of life
時間枠:At baseline, 3, 6 and 12-months follow-up.
|
EQ-5D-5L will be used to assess five domains of patient reported outcomes and for economic evaluation of the interventions. |
At baseline, 3, 6 and 12-months follow-up.
|
|
Health related quality of life - Visual Analog Scale
時間枠:At baseline, 3, 6 and 12-months follow-up.
|
EQ VAS will be used to assess patient reported outcomes for self-rated health and for economic evaluation of the interventions. |
At baseline, 3, 6 and 12-months follow-up.
|
その他の成果指標
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Client satisfaction questionnaires (CSQ-I)
時間枠:At 3 months follow-up.
|
The 8-item questionnaire assesses how satisfied the participants are with the interventions, only administrated to those who are in the interventional arms. |
At 3 months follow-up.
|
協力者と研究者
出版物と役立つリンク
便利なリンク
研究記録日
主要日程の研究
研究開始 (実際)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
その他の研究ID番号
- 870757
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
The dataset underlying the results will be shared together with publications.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。